Global Radiodermatitis Market to Reach US$ 660.3 Million by 2032, Catalyzed by Rising Incidences of Different Cancers

March 07, 2023 | Healthcare

IMARC Group’s latest report, titled “Radiodermatitis Market Report by Product (Topical, Oral, Dressings), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032,” finds that the global radiodermatitis market size reached US$ 499.5 Million in 2023. Radiodermatitis, also known as radiation dermatitis, is a skin condition that usually occurs as a side effect during cancer treatment or after interventional radiology. It is caused by radiation therapy used for the treatment of patients with cancers of the breast, lungs, skin, neck, head, or perineum region, wherein the skin is part of the target field. It can be treated using various products, such as hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, anti-inflammatory agents, topical antibiotics, and corticosteroids. Since it helps minimize discomfort, reduce pain, and prevent interruption in ongoing therapy while enhancing the overall quality of the patient’s life, radiodermatitis treatment has gained immense traction across the globe. 

Global Radiodermatitis Market Trends:

The rising incidences of different cancers among the masses owing to unhealthy lifestyles and excessive smoking and alcohol consumption have led to the widespread adoption of radiation therapy as a treatment option. This, coupled with the surging need to manage the adverse side effects of radiation therapy, represents the primary factor driving the market growth. Apart from this, the increasing public and private funding in ongoing research and development (R&D) activities in the field of life sciences are positively influencing the market growth. In addition, numerous governmental and non-governmental organizations are taking favorable initiatives to spread awareness about the available radiodermatitis treatment and management solutions. Along with this, the escalating demand for novel wound care products and the increasing number of clinical trials are contributing to the market growth. Furthermore, several key players are launching innovative product variants to expand their product portfolio and customer base. In line with this, elevating sales of generic drugs via online and offline distribution channels has catalyzed market growth. Other factors, including the expanding geriatric population, improvements in the healthcare infrastructure, easy availability of supportive healthcare reimbursement policies, and rising consumer healthcare spending, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 660.3 Million by 2032, growing at a CAGR of 3.06% during 2024-2032.

Market Summary:

  • Based on the product, the market has been segregated into topical (corticosteroids, hydrophilic creams, antibiotics, and others), oral, and dressings (hydrogel and hydrocolloid dressings, no sting barrier film, honey-impregnated gauze, silicone-coated dressings, and others).
  • On the basis of the distribution channel, the market has been classified into hospital, retail, and online pharmacies. 
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB, and Stratpharma AG.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Product, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Mölnlycke Health Care AB and Stratpharma AG
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Radiodermatitis Market to Reach US$ 660.3 Million by 2032, Catalyzed by Rising Incidences of Different Cancers
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More